Checking ACAD unusual options activity helps you spot when traders are making outsized bets on Acadia Pharmaceuticals Inc before the broader market catches on. Acadia Pharmaceuticals Inc's unusual options activity flags contracts trading at multiples of their average daily volume, often signaling that informed money is positioning ahead of a catalyst. Use our scanner to monitor ACAD unusual options activity today and surface the prints that deserve a second look.
Unusual options flow typically refers to trades where volume vastly exceeds open interest at a given strike, or where total contract volume on a name spikes well above its norm. Watching ACAD unusual options flow today can reveal large block trades, sweeps across exchanges, and aggressive directional bets. Tracking ACAD unusual options volume across calls and puts helps you separate hedging activity from genuinely speculative positioning, and ACAD unusual options flow data becomes especially valuable around earnings, product launches, and macro events.
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's pipeline include, pimavanserin, under phase 3 development for the treatment of Alzheimer's disease psychosis, and negative symptoms of schizophrenia; Trofinetide, a novel synthetic analog, under phase 3 development for the treatment of Rett syndrome; ACP-044, a novel first-in-class orally administered non-opioid analgesic, under phase 2 development for treating acute and chronic pain; and ACP-319, a positive allosteric modulator of the muscarinic receptor, under phase 1 development for treating schizophrenia and cognition in Alzheimer's.
ACADIA Pharmaceuticals Inc. was founded in 1993 and is headquartered in San Diego, California.
Catalysts rarely arrive without a footprint, and ACAD unusual options activity is often where that footprint shows up first. Our scanner tracks Acadia Pharmaceuticals Inc's unusual options flow in real time, ranks prints by volume-to-open-interest, premium spent, and aggressor side, and separates real conviction from noise. Whether you're looking at ACAD unusual options volume on the call side or chasing put sweeps, Acadia Pharmaceuticals Inc's unusual options flow today is one click away, so put it on your radar before the headlines hit.
